Andrew Hart
About Andrew Hart
Andrew Hart is a Scientist II specializing in DMPK at Wave Life Sciences, where he has worked since 2022. He has extensive experience in the pharmaceutical field, having held various research roles at notable organizations including Agios Pharmaceuticals and Eisai US.
Work at Wave Life Sciences
Andrew Hart currently serves as Scientist II in the DMPK (Drug Metabolism and Pharmacokinetics) department at Wave Life Sciences. He has been in this role since 2022. Prior to this position, he worked at Wave Life Sciences as Scientist I in both DMPK and Bioanalytical and Biomarker Development from 2021 to 2022 and 2020 to 2021, respectively. His tenure at Wave Life Sciences has spanned multiple roles, showcasing his expertise in drug development and analysis.
Previous Employment History
Before joining Wave Life Sciences, Andrew Hart held several positions in the pharmaceutical and research sectors. He worked as a Senior Research Associate at Agios Pharmaceuticals for six months in 2012. He also served as a Principal Researcher at Eisai US from 2014 to 2018 and as a Senior Researcher at the same company from 2012 to 2014. His experience includes a role as a Research Technician at Massachusetts General Hospital from 2011 to 2012 and a Research Assistant at NASA for one month in 2009.
Education and Expertise
Andrew Hart earned a Master of Science (M.S.) in Analytical Chemistry from the University of New Hampshire, where he studied from 2009 to 2011. He also holds a Bachelor of Science (B.S.) in Chemistry from the same institution, completing his undergraduate studies from 2005 to 2009. His educational background provides a strong foundation for his work in drug metabolism and pharmacokinetics.
Research and Development Experience
Throughout his career, Andrew Hart has accumulated extensive experience in research and development. He worked as a Preparation Laboratory Intern at Analytics Environmental Laboratory LLC from 2007 to 2011, where he gained practical laboratory skills. His roles have consistently focused on drug metabolism and pharmacokinetics, contributing to advancements in pharmaceutical research.